Your browser doesn't support javascript.
loading
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
De Jesus-Acosta, Ana; Sugar, Elizabeth A; O'Dwyer, Peter J; Ramanathan, Ramesh K; Von Hoff, Daniel D; Rasheed, Zeshaan; Zheng, Lei; Begum, Asma; Anders, Robert; Maitra, Anirban; McAllister, Florencia; Rajeshkumar, N V; Yabuuchi, Shinichi; de Wilde, Roeland F; Batukbhai, Bhavina; Sahin, Ismet; Laheru, Daniel A.
Afiliación
  • De Jesus-Acosta A; Department of Medical Oncology, Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD, USA. adejesu1@jhmi.edu.
  • Sugar EA; Department of Biostatistics, the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • O'Dwyer PJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Ramanathan RK; Honor Health Research Institute & Translational Genomics Research Institute, Scottsdale, AZ, USA.
  • Von Hoff DD; Honor Health Research Institute & Translational Genomics Research Institute, Scottsdale, AZ, USA.
  • Rasheed Z; Department of Medical Oncology, Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD, USA.
  • Zheng L; Department of Medical Oncology, Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD, USA.
  • Begum A; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Anders R; Departments of Pathology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Maitra A; Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McAllister F; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rajeshkumar NV; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Yabuuchi S; Department of Surgery, Sendai South Hospital, Sendai, Japan.
  • de Wilde RF; Departments of Pathology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Batukbhai B; Department of Medical Oncology, Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD, USA.
  • Sahin I; Department of Engineering, Texas Southern University, Houston, TX, USA.
  • Laheru DA; Department of Medical Oncology, Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD, USA.
Br J Cancer ; 122(4): 498-505, 2020 02.
Article en En | MEDLINE | ID: mdl-31857726
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Anilidas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Piridinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Anilidas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos